Effects of Subclinical Hypothyroidism on Nephropathy Complicating Type 2 Diabetes: The Fremantle Diabetes Study Phase II

J Clin Endocrinol MetabPublished Longitudinal observational study

Authors' conclusion

Persistent SCH/overt hypothyroidism was associated with incident increased albuminuria not observed in euthyroid participants. Assessment of thyroid function in all patients with T2DM may be indicated, as some previous studies provide evidence that thyroxine replacement may ameliorate albuminuria.

Study context

Population
Urban community-dwelling people with T2D in the Fremantle Diabetes Study Phase II, without known thyroid dysfunction at baseline and follow-up
Participants
725 people
Exposure
Persistent vs transient subclinical hypothyroidism (SCH)/overt hypothyroidism vs stable euthyroidism
  • Euthyroidismn = 683reference
  • Transient SCH/overt hypothyroidismn = 18
  • Persistent SCH/overt hypothyroidismn = 24
Outcome
Changes in eGFR and urine albumin:creatinine ratio (ACR) by thyroid status
Follow-up
Mean ± SD 4.3 ± 0.4 years
Methodological detailsprospective, community-based
  • Prospective
  • Community-based

Main finding

As reported in the abstract

ΔACR · mean 4.3 years

Persistent SCH/overt hypothyroidism

22.0

mean · SD 81.4 · mg/mmol

Euthyroidism

0.4

mean · SD 36.7 · mg/mmol

Transient SCH/overt hypothyroidism

−0.3

mean · SD 5.7 · mg/mmol

P = 0.027

Observational data: associations, not effects.

Further findings

ΔACR excluding baseline albumin:creatinine ratio (ACR) > 30 mg/mmol

Similar results

Original publication

Effects of Subclinical Hypothyroidism on Nephropathy Complicating Type 2 Diabetes: The Fremantle Diabetes Study Phase II. J Clin Endocrinol Metab. Published 29 August 2025. doi:10.1210/clinem/dgaf485

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.